Qianjiang Yongan Pharmaceutical Co Ltd (002365) — Free Cash Flow Generation Index
Qianjiang Yongan Pharmaceutical Co Ltd (002365) has a Free Cash Flow Generation Index of 0.80x as of September 2025. Free cash flow of CN¥46.33 Million represents 1% of operating cash flow (CN¥58.18 Million). See Qianjiang Yongan Pharmaceutical Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Qianjiang Yongan Pharmaceutical Co Ltd Free Cash Flow Generation Index (2006–2024)
Historical FCF Generation Index trend for Qianjiang Yongan Pharmaceutical Co Ltd across 19 annual periods. Explore how well can Qianjiang Yongan Pharmaceutical Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Qianjiang Yongan Pharmaceutical Co Ltd (2006–2024)
Year-by-year Free Cash Flow Generation Index for Qianjiang Yongan Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market value of Qianjiang Yongan Pharmaceutical Co Ltd.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.12x | CN¥-12.33 Million | CN¥105.71 Million | CN¥118.04 Million | ▼ -128.4% |
| 2023 | 0.41x | CN¥100.46 Million | CN¥244.26 Million | CN¥120.74 Million | ▼ -33.1% |
| 2022 | 0.62x | CN¥238.21 Million | CN¥387.28 Million | CN¥149.07 Million | ▲ +61.6% |
| 2021 | 0.38x | CN¥38.76 Million | CN¥101.81 Million | CN¥63.05 Million | ▼ -23.1% |
| 2020 | 0.49x | CN¥102.25 Million | CN¥206.66 Million | CN¥104.41 Million | ▲ +12.7% |
| 2019 | 0.44x | CN¥105.15 Million | CN¥239.55 Million | CN¥134.39 Million | ▲ +209.6% |
| 2018 | 0.14x | CN¥44.53 Million | CN¥314.02 Million | CN¥269.50 Million | ▲ +130.4% |
| 2017 | -0.47x | CN¥-92.15 Million | CN¥197.32 Million | CN¥289.47 Million | ▼ -188.9% |
| 2016 | 0.53x | CN¥44.40 Million | CN¥84.53 Million | CN¥40.13 Million | ▲ +1.6% |
| 2015 | 0.52x | CN¥36.49 Million | CN¥70.61 Million | CN¥34.12 Million | ▲ +131.7% |
| 2014 | -1.63x | CN¥-31.42 Million | CN¥19.26 Million | CN¥50.69 Million | ▼ -186.2% |
| 2013 | -0.57x | CN¥-36.28 Million | CN¥63.65 Million | CN¥99.93 Million | ▲ +18.4% |
| 2012 | -0.70x | CN¥-49.43 Million | CN¥70.75 Million | CN¥120.18 Million | ▲ +59.3% |
| 2011 | -1.72x | CN¥-156.80 Million | CN¥91.23 Million | CN¥248.03 Million | ▼ -25.3% |
| 2010 | -1.37x | CN¥-60.45 Million | CN¥44.06 Million | CN¥104.52 Million | ▼ -423.5% |
| 2009 | -0.26x | CN¥-9.55 Million | CN¥36.43 Million | CN¥45.98 Million | ▼ -148.1% |
| 2008 | 0.54x | CN¥86.28 Million | CN¥158.47 Million | CN¥72.19 Million | ▲ +10707.9% |
| 2007 | 0.01x | CN¥307.69K | CN¥61.08 Million | CN¥60.77 Million | ▼ -98.8% |
| 2006 | 0.43x | CN¥13.44 Million | CN¥31.11 Million | CN¥17.68 Million | — |